Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Fractyl Health Q1 2026 Earnings Call - Pivotal Data Countdown and Capital Discipline
Fractyl Health reported a shift to net income in Q1 2026, driven by a $30.1 million non-cash accounting adjustment, while maintaining a disciplined cash runway into early 2027. The company is advancin...
- Revita Pivotal Trial on Track: The REMAIN-1 pivotal study completed randomizations in February with over 300 participants across 30+ sites. Top-line 6-month data is expected in early Q4 2026, with management targeting a strong result defined as roughly a 50% reduction in weight regain compared to the expected 15% rebound in GLP-1 discontinuers.
- Capital Discipline and Runway: Fractyl Health holds approximately $63.2 million in cash and cash equivalents as of March 31, 2026. Management explicitly closed its ATM facility and committed to no capital raises before pivotal data, extending runway into early 2027 to fund operations and the Rejuva program.
- Rejuva Gene Therapy Advances: Fractyl received authorization from the Netherlands to initiate the phase I/II first-in-human study for RJVA-001, an AAV-based gene therapy for type 2 diabetes. First patient dosing is expected in H2 2026, funded within existing cash runway.
- +7 more takeaways
Hyperfine Q1 2026 Earnings Call - Revenue Jumps 83% as Ultra-Low Field MRI Platform Expands into Neurology Offices and International Markets
Hyperfine delivered a formidable start to 2026, posting $3.9 million in revenue, a sharp 83% year-over-year jump driven by strong demand for its next-generation Swoop subsystem across hospitals and ne...
- Revenue surged 83% year-over-year to $3.9 million, marking the second-highest quarter in company history and driven by the third full quarter of next-generation subsystem sales.
- Gross margin expanded to 50.7% from 41.3% in the prior year period, representing 940 basis points of improvement and marking the third consecutive quarter above 50%.
- Cash burn declined 13% to $8.8 million, down from $10.1 million in Q1 2025, as management enforced spending discipline and realized benefits from prior restructuring.
- +7 more takeaways
Tenon Medical Q1 2026 Earnings Call - Gross Margin Expansion Hits 68.5% on Dual-Platform Growth
Tenon Medical reported a record first quarter in 2026, with revenue nearly doubling year-over-year to $1.4 million and gross margins expanding sharply to 68.5%. The surge was driven by higher Catamara...
- Revenue surged 90% year-over-year to $1.4 million, marking the highest first-quarter revenue in company history.
- Gross margin expanded 24 percentage points to 68.5%, up from 44.5% in Q1 2025, driven by better fixed-cost absorption and operational efficiency.
- SImmetry+ contributed meaningfully to revenue for the first full quarter following the SiVantage asset acquisition in August 2025.
- +7 more takeaways
HireQuest Q1 2026 Earnings Call - Demand Stabilizes, M&A Pressure Builds
HireQuest delivered a resilient first quarter, with total revenue of $6.5 million and adjusted net income of $0.13 per share. The company’s franchise model insulated it from the broader staffing indus...
- Total revenue of $6.5 million in Q1 2026, down 12.7% year-over-year, primarily due to the January divestiture of MRI Network permanent placement assets.
- Adjusted net income held steady at $0.13 per share, with adjusted EBITDA of $2.7 million, demonstrating margin resilience despite macro headwinds.
- System-wide sales fell to $102.6 million from $118.4 million, but excluding divestiture impact, underlying sales were nearly flat year-over-year, signaling stabilization.
- +7 more takeaways
SideChannel Q2 FY2026 Earnings Call - Deliberate Revenue Decline Fuels Platform Transition
SideChannel reported a 11.9% year-over-year revenue decline to $1.58 million in Q2 FY2026, driven by a 28.4% drop in vCISO services revenue. Management framed this not as a setback, but as an intentio...
- Total revenue declined 11.9% year-over-year to $1.58 million in Q2 FY2026, missing prior growth trajectories.
- vCISO services revenue fell 28.4% year-over-year, reflecting a deliberate pullback from hourly consulting engagements.
- Gross margin expanded 380 basis points to 53.5%, demonstrating early operational leverage as the company shifts to platform models.
- +9 more takeaways
Curis Q1 2026 Earnings Call - Emavusertib Pipeline Expansion and Cash Runway Extension
Curis delivered a mixed Q1 2026 update, posting a wider net loss driven by a non-cash fair value adjustment on warrant liabilities, while simultaneously advancing its emavusertib pipeline into new ind...
- Curis reported a Q1 2026 net loss of $24.2 million ($1.25/share), an increase from $10.6 million in Q1 2025, primarily due to a fair value change in warrant liabilities from the January 2026 PIPE financing.
- R&D expenses decreased to $6.4 million from $8.5 million year-over-year, driven by lower employee-related and manufacturing costs as the company transitions from early-stage development to clinical execution.
- G&A expenses rose to $5.1 million from $4.0 million, reflecting costs associated with the January 2026 PIPE financing, partially offset by lower employee costs.
- +9 more takeaways
Karman Space & Defense Q1 2026 Earnings Call - Record Revenue and Backlog Surge
Karman Space & Defense delivered a record-breaking first quarter for fiscal 2026, with revenue jumping 51% to $151 million and adjusted EBITDA climbing nearly 50% to $45 million. The company's backlog...
- Revenue reached a record $151 million in Q1 fiscal 2026, representing a 51% year-over-year increase, with half of the growth attributed to the January acquisition of Seemann Composites and Materials Sciences Corporation.
- Adjusted EBITDA hit an all-time high of $45 million, up nearly 50% year-over-year, while net income flipped from a $5 million loss to $8 million profit.
- Backlog grew 61% to over $1 billion, providing strong visibility into future revenue streams and supporting the company's raised full-year guidance.
- +7 more takeaways
TransAct Technologies Q1 2026 Earnings Call - Recurring Revenue Surge and Strategic Shift to Software Monetization
TransAct Technologies delivered a solid Q1 2026, with total net sales rising 10% year-over-year to $14.4 million and adjusted EBITDA flipping to a positive $1.4 million, driven by strong momentum in i...
- Total net sales rose 10% year-over-year to $14.4 million, with adjusted EBITDA turning positive at $1.4 million, up from a negative $499,000 in Q4 2025.
- Recurring FST revenue surged 26% to $3.3 million, with software revenue growing 23% year-over-year, highlighting the successful pivot to a high-margin, predictable software-as-a-service model.
- Annual Recurring Revenue (ARR) reached $3.3 million, encompassing software, contracted support services, and consumable labels, signaling strong monetization of the nearly 20,000 online terminal install base.
- +7 more takeaways
Arteris Q1 2026 Earnings Call - Record Revenue and Raised Guidance on AI Chip Demand
Arteris delivered a record-breaking first quarter in 2026, with revenue climbing 39% year-over-year to $22.9 million and trailing twelve-month royalties surging 67% to $9.9 million. The company’s stra...
- Record revenue of $22.9 million, up 39% year-over-year, beating the top end of guidance.
- Trailing twelve-month royalties surged 67% to $9.9 million, driven by AI chip demand and higher-priced semiconductor nodes.
- Annual contract value plus royalties reached a record $92.8 million, up 39% year-over-year.
- +7 more takeaways
GCT Semiconductor Holding Q1 2026 Earnings Call - 5G Chipset Shipments Surge 58% as Revenue Jumps 287%
GCT Semiconductor moved a critical step closer to commercial scale in Q1 2026, delivering 3,000 5G chipsets and posting revenue that nearly tripled to $1.9 million. The growth was fueled by a mix of p...
- 5G chipset shipments reached 3,000 units in Q1 2026, marking a 58% sequential increase and signaling early commercial traction.
- Total revenue surged 287% to $1.9 million, driven by a $0.4 million rise in product sales and a $1.0 million jump in service revenue.
- Gross margins expanded to 49.3% from 18.0% year-over-year, largely due to a higher proportion of high-margin service and licensing revenue.
- +7 more takeaways